kneat.com (KSI) Stock Overview
Designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
KSI Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
kneat.com, inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$5.42 |
| 52 Week High | CA$6.73 |
| 52 Week Low | CA$3.23 |
| Beta | 1.32 |
| 1 Month Change | 20.71% |
| 3 Month Change | 36.18% |
| 1 Year Change | -15.97% |
| 3 Year Change | 100.74% |
| 5 Year Change | 81.88% |
| Change since IPO | 1,448.57% |
Recent News & Updates
Narrative Update • May 13
KSI: Life Sciences Validation Adoption And Special Committee Review Will Support Future Upside
Analysts have increased the fair value estimate for kneat.com from CA$5.70 to CA$5.90, aligning it with recent Street price target adjustments in the CA$5.50 to CA$6.25 range and reflecting views on the company's growth profile, margins and P/E expectations. Analyst Commentary Recent Street research around kneat.com has focused on recalibrating price targets while keeping positive ratings in place.Narrative Update • Apr 21
KSI: Pharma Packaging Agreements And Data Integrity Adoption Will Support Future Upside
Narrative Update Analysts have trimmed their blended price target on kneat.com by CA$1.00 to CA$5.50, reflecting recent target cuts from CA$6.50, while still citing supportive views on the business outlook. Analyst Commentary Recent research suggests that while price targets on kneat.com have been reset to CA$5.50, the general tone from covering firms still leans supportive, with ratings such as Buy and Outperformer maintained alongside a fresh, constructive initiation.Recent updates
Narrative Update • May 13
KSI: Life Sciences Validation Adoption And Special Committee Review Will Support Future Upside
Analysts have increased the fair value estimate for kneat.com from CA$5.70 to CA$5.90, aligning it with recent Street price target adjustments in the CA$5.50 to CA$6.25 range and reflecting views on the company's growth profile, margins and P/E expectations. Analyst Commentary Recent Street research around kneat.com has focused on recalibrating price targets while keeping positive ratings in place.Narrative Update • Apr 21
KSI: Pharma Packaging Agreements And Data Integrity Adoption Will Support Future Upside
Narrative Update Analysts have trimmed their blended price target on kneat.com by CA$1.00 to CA$5.50, reflecting recent target cuts from CA$6.50, while still citing supportive views on the business outlook. Analyst Commentary Recent research suggests that while price targets on kneat.com have been reset to CA$5.50, the general tone from covering firms still leans supportive, with ratings such as Buy and Outperformer maintained alongside a fresh, constructive initiation.Narrative Update • Apr 05
KSI: Global Pharma Agreements And Data Integrity Adoption Will Support Future Margin Expansion
Analysts have trimmed their average price target on kneat.com to CA$5.50 from CA$6.50, citing refreshed assumptions around discount rates, long term growth expectations and valuation multiples, while generally maintaining positive ratings on the shares. Analyst Commentary Recent research on kneat.com points to a reset in expectations, with price targets grouped around CA$5.50 and ratings that remain generally constructive on the company’s execution and growth potential.Narrative Update • Mar 21
KSI: Data Integrity Adoption And New Pharma Wins Will Support Future Margin Expansion
The analyst price target for kneat.com has been trimmed to CA$5.50 from CA$6.50. Analysts are factoring in an updated fair value of CA$5.70, a modestly higher discount rate, and adjusted revenue growth and profit margin assumptions, while still citing generally positive research commentary on the shares.Narrative Update • Mar 07
KSI: Data Integrity Adoption Will Support Future Margin Expansion Despite Reset Expectations
Analysts have reduced their fair value estimate for kneat.com to CA$5.75 from CA$6.67. This change reflects recent cuts to Street price targets to around CA$5.50 and more cautious assumptions on growth, margins, and future P/E.Narrative Update • Feb 20
KSI: Data Integrity Adoption Will Support Future Margin Expansion Potential
Analysts have maintained their CA$6.67 price target on kneat.com, citing supportive TD Securities research. The research highlights the company’s growth profile and long-term margin potential, as reflected in modest adjustments to the discount rate, revenue growth, and future P/E assumptions.Narrative Update • Feb 06
KSI: Global Validation Wins And Bullish Coverage Will Support Future Upside
Analysts have trimmed their price expectations for kneat.com, with recent targets moving from C$7.50 to C$5.50 and from C$8.50 to C$7.50. This reflects updated views on fair value, profitability assumptions and future P/E levels, while a new bullish initiation from TD Securities highlights ongoing interest in the name.Narrative Update • Jan 23
KSI: Global Validation Agreements Will Support Future Upside Despite Lowered Street Expectations
Narrative update on kneat.com The analyst price target for kneat.com has been revised lower to C$5.50 to C$7.50, down from C$7.50 to C$8.50, as analysts adjust their views while maintaining positive ratings on the shares. Analyst Commentary Recent research reflects a mixed but generally constructive stance on kneat.com, with both supporting and cautionary points tied to the revised price targets of C$5.50 and C$7.50 and the maintained positive ratings.Narrative Update • Jan 08
KSI: Global Validation Agreements Will Support Future Upside Despite Recent Estimate Revisions
Analysts nudged their fair value estimate for kneat.com to C$6.80 from C$6.60. Recent Street price target updates to C$5.50 and C$7.50 helped frame the new outlook on discount rates, revenue growth, profit margins and future P/E assumptions.Narrative Update • Dec 15
KSI: Expanding Global Validation Agreements Will Drive Future Outperformance
We lower our Kneat.com price target to C$5.50 from C$7.50, reflecting analysts' reduced near term expectations for valuation multiples, despite largely unchanged long term growth and margin assumptions. Analyst Commentary Recent Street research reflects a more tempered near term outlook for Kneat.com, with price targets revised lower but positive ratings maintained, signaling continued confidence in the company’s underlying growth trajectory.Narrative Update • Dec 01
KSI: Expansion Of Global Customer Agreements Will Drive Outperformance Ahead
Analysts have reduced their average price target for kneat.com from $6.80 to $6.60. This change is attributed to recent downward revisions to growth and profit forecasts.Analysis Article • Nov 18
Market Cool On kneat.com, inc.'s (TSE:KSI) Revenues Pushing Shares 26% Lower
The kneat.com, inc. ( TSE:KSI ) share price has fared very poorly over the last month, falling by a substantial 26...Narrative Update • Nov 17
KSI: Momentum In Securing New Customers Will Drive Performance Ahead
Analysts have lowered their price targets for kneat.com. Target estimates have decreased from C$8.50 and C$7.50 previously to updated levels of C$7.50 and C$5.50 respectively, citing slower expected revenue growth and a slightly higher discount rate as key factors in their revised outlook.
New Narrative • Mar 29
Life Sciences Wins And Expanded Sales Will Open Future Markets
Strategic wins and expansions in multiple sectors, alongside enhanced AI tools, are expected to boost revenue and improve net margins.Analysis Article • Mar 01
kneat.com, inc. (TSE:KSI) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for kneat.com, inc. ( TSE:KSI ) shareholders, with its shares surging 15% to CA$6.88 in...Analysis Article • Feb 22
A Look At The Intrinsic Value Of kneat.com, inc. (TSE:KSI)
Key Insights The projected fair value for kneat.com is CA$5.19 based on 2 Stage Free Cash Flow to Equity Current share...Analysis Article • May 11
Investors Still Waiting For A Pull Back In kneat.com, inc. (TSE:KSI)
With a price-to-sales (or "P/S") ratio of 10.1x kneat.com, inc. ( TSE:KSI ) may be sending very bearish signals at the...Analysis Article • Nov 08
Is kneat.com (TSE:KSI) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Aug 04
Here's Why We're Not Too Worried About kneat.com's (TSE:KSI) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Analysis Article • Jun 30
Fewer Investors Than Expected Jumping On kneat.com, inc. (TSE:KSI)
There wouldn't be many who think kneat.com, inc.'s ( TSE:KSI ) price-to-sales (or "P/S") ratio of 8.7x is worth a...Analysis Article • Jan 27
kneat.com (TSE:KSI) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...Shareholder Returns
| KSI | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 6.3% | -2.5% | 0.4% |
| 1Y | -16.0% | -7.8% | 33.0% |
Return vs Industry: KSI underperformed the Canadian Healthcare Services industry which returned -7.4% over the past year.
Return vs Market: KSI underperformed the Canadian Market which returned 32.9% over the past year.
Price Volatility
| KSI volatility | |
|---|---|
| KSI Average Weekly Movement | 6.5% |
| Healthcare Services Industry Average Movement | 11.1% |
| Market Average Movement | 10.1% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 3.8% |
Stable Share Price: KSI has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: KSI's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 343 | Eddie Ryan | kneat.com |
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides professional services, including consulting, training, process mapping, project management, and other services.
kneat.com, inc. Fundamentals Summary
| KSI fundamental statistics | |
|---|---|
| Market cap | CA$521.04m |
| Earnings (TTM) | -CA$8.44m |
| Revenue (TTM) | CA$66.52m |
7.8x
P/S Ratio-61.7x
P/E RatioIs KSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KSI income statement (TTM) | |
|---|---|
| Revenue | CA$66.52m |
| Cost of Revenue | CA$15.54m |
| Gross Profit | CA$50.97m |
| Other Expenses | CA$59.41m |
| Earnings | -CA$8.44m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.088 |
| Gross Margin | 76.63% |
| Net Profit Margin | -12.69% |
| Debt/Equity Ratio | 31.6% |
How did KSI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/31 01:27 |
| End of Day Share Price | 2026/05/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
kneat.com, inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gavin Fairweather | ATB Cormark |
| Douglas Taylor | Canaccord Genuity |
| Stephanie Price | CIBC Capital Markets |